Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP

Clinical trial NCT00407511 · COMPLETED

Trial details

NCT number: NCT00407511
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Peripheral Neuropathic Pain (DPN)Postherpetic Neuralgia (PHN)HIV-related Neuropathic Pain (HIV)Chemotherapy Induced Neuropathic Pain

Start date: 2007-01-01
Primary completion: 2008-07-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.